Search Within

Shakeel Modak

  1. "2025"
Formats
  1. Journal Article (2)
Groups
  1. Neuroblastoma Service (2)
  2. Pediatrics, Department of (2)
  3. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1)
  4. Biostatistics Service (1)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1)
  6. Epidemiology and Biostatistics (1)

More Groups

People
  1. Ellen Basu (2)
  2. Audrey Mauguen (1)
  3. Brian Kushner (1)
  4. Eloisa Balquin (1)
  5. Irene Cheung (1)
  6. Kim Kramer (1)

More People

Years
  1. 2025 (2)
Publications
  1. Clinical Cancer Research (1)
  2. Nuclear Medicine Communications (1)
Publishers
  1. American Association for Cancer Research (1)
  2. Lippincott Williams & Wilkins (1)

Results (2)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II trial of naxitamab plus stepped-up dosing of GM-CSF for patients with high-risk neuroblastoma in first complete remission
    Journal Article

    Kushner, B. H.; Modak, S.; Mauguen, A.; Basu, E. M.; Kramer, K.; Roberts, S. S.; Cheung, I. Y.; Cheung, N. K. V.
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Safety observations in neuroblastoma patients undergoing (18)F- mFBG PET
    Journal Article

    Pandit-Taskar, N.; Basu, E.; Balquin, E.; Mozley, P. D.; Jacobson, A. F.; Modak, S.
    Nuclear Medicine Communications (2025)

    Fulltext@MSK | Save